Insider acquisitions

Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.

Reset
Form 4, 4/A, 5 & 5/AAmounts retain the reported currency, when available.

Transaction timeline & trade size

Choose a reporting owner, transaction period, and security. Open any point for the filing.

Purchases in this page4
Other acquisitions46
Reporting owners31
Sales (not included)Not included in this datasetCheck original SEC filings

Oct 28, 2025 – Oct 30, 2025 · Transaction dates · Current page sample

Reported transaction sizes · security units

Catalyst Bancorp, Inc. · Common Stock · Purchase (code P) · Non-derivative · Not reported

Reported transaction sizes by transaction date.Each point is one transaction for the selected company, security, and acquisition type. Reporting owners, exact quantities, and values are also provided in the table. These are filing amounts, not a stock-price series.4,6500Catalyst Bancorp, Inc. · Kleiser Kirk E. (Director) · Purchase · October 28, 2025 · Quantity 4,650 · Price 13.4099 · Reference value 62,356.035 · Not reportedCatalyst Bancorp, Inc. · Kleiser Kirk E. (Director) · Purchase · October 28, 2025 · Quantity 100 · Price 13.4 · Reference value 1,340 · Not reportedOct 28, 2025Oct 30, 2025No reported values to plot for this selection.

Swipe the chart to see the full date range. Exact records are available in the table below.

2 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

50 dated transactions in this page sample · 31 reporting owners.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition typeQuantityPriceReference valueCurrency
Oct 28, 2025CULLEN/FROST BANKERS, INC.Restricted Stock UnitsHenson Matthew Bradley (Chief Accounting Officer)Stock award73000Not reported
Oct 28, 2025CULLEN/FROST BANKERS, INC.Restricted Stock UnitsGeddes Dan (GEVP & Chief Financial Officer)Stock award3,95600Not reported
Oct 29, 2025Primoris Services CorpCommon StockSaluja Harpreet (Director)Stock award302Not reportedNot reportedNot reported
Oct 28, 2025CULLEN/FROST BANKERS, INC.Restricted Stock UnitsWilson Kenneth L. (GEVP Chief Wealth Officer)Stock award3,34700Not reported
Oct 28, 2025CULLEN/FROST BANKERS, INC.Restricted Stock UnitsKasanoff Howard L. (GEVP Chief Credit Officer)Stock award2,73900Not reported
Oct 29, 2025Primoris Services CorpCommon StockChing Michael E. (Director)Stock award302Not reportedNot reportedNot reported
Oct 28, 2025NXP Semiconductors N.V.Restricted Stock UnitBetz William (EVP & CFO)Stock award5,21300Not reported
Oct 28, 2025Catalyst Bancorp, Inc.Common StockKleiser Kirk E. (Director)Purchase4,65013.409962,356.035Not reported
Oct 28, 2025Catalyst Bancorp, Inc.Common StockKleiser Kirk E. (Director)Purchase10013.41,340Not reported
Oct 28, 2025CULLEN/FROST BANKERS, INC.Restricted Stock UnitsRhodes Coolidge E JR (Group EVP General Counsel/Sec)Stock award4,26000Not reported
Oct 28, 2025Janux Therapeutics, Inc.Common StockMeyer Andrew Hollman (Chief Business Officer)Exercise / conversion6,66610.5970,592.94Not reported
Oct 28, 2025Janux Therapeutics, Inc.Common StockMeyer Andrew Hollman (Chief Business Officer)Exercise / conversion9,9994.2142,095.79Not reported
Oct 29, 2025Primoris Services CorpCommon StockRodriguez Jose Ramon (Director)Stock award302Not reportedNot reportedNot reported
Oct 28, 2025Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareRagosa Mark (CHIEF FINANCIAL OFFICER)Exercise / conversion10030.933,093Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common Stockvan Houte Hans (Chief Financial Officer)Exercise / conversion2,85800Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common Stockvan Houte Hans (Chief Financial Officer)Exercise / conversion3,75000Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common Stockvan Houte Hans (Chief Financial Officer)Exercise / conversion2,00000Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common Stockvan Houte Hans (Chief Financial Officer)Exercise / conversion2,88600Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common StockRing Christine (Chief Legal Officer)Exercise / conversion2,85800Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common StockRing Christine (Chief Legal Officer)Exercise / conversion3,75000Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common StockRing Christine (Chief Legal Officer)Exercise / conversion2,00000Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common StockRing Christine (Chief Legal Officer)Exercise / conversion1,92400Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common StockHansen Gwenn (Chief Scientific Officer)Exercise / conversion2,85800Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common StockHansen Gwenn (Chief Scientific Officer)Exercise / conversion3,75000Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common StockHansen Gwenn (Chief Scientific Officer)Exercise / conversion2,00000Not reported
Oct 30, 2025Nurix Therapeutics, Inc.Common StockHansen Gwenn (Chief Scientific Officer)Exercise / conversion3,20700Not reported
Oct 30, 2025Bakkt, Inc.Class A Common StockALFRED MICHAEL (Director)Stock award13900Not reported
Oct 28, 2025NXP Semiconductors N.V.Restricted Stock UnitJensen Christopher L (EVP, Chief People Officer)Stock award4,64900Not reported
Oct 28, 2025Sky Quarry Inc.Common SharesSealock David (Former CEO)Other acquisition100,0000.48848,800Not reported
Oct 28, 2025CULLEN/FROST BANKERS, INC.Restricted Stock UnitsSeveryn Carol Jean (GEVP and Chief Risk Officer)Stock award4,13800Not reported
Oct 29, 2025Travere Therapeutics, Inc.Common StockDube Eric M (CHIEF EXECUTIVE OFFICER · Director)Exercise / conversion27,12815.46419,398.88Not reported
Oct 28, 2025Travere Therapeutics, Inc.Common StockDube Eric M (CHIEF EXECUTIVE OFFICER · Director)Exercise / conversion92,87215.461,435,801.12Not reported
Oct 29, 2025CHEMUNG FINANCIAL CORPCOMMON STOCKSTREETER JEFFREY B (Director)Purchase2,18451.9231113,400.0504Not reported
Oct 30, 2025Integer Holdings CorpCommon StockKhales Payman (President & CEO · Director)Purchase3,12764.94203,067.38Not reported
Oct 30, 2025ROKU, INCClass A Common StockWood Anthony J. (CEO and Chairman BOD · Director · 10% owner)Conversion18,700Not reportedNot reportedNot reported
Oct 28, 2025ROKU, INCClass A Common StockWood Anthony J. (CEO and Chairman BOD · Director · 10% owner)Conversion2,900Not reportedNot reportedNot reported
Oct 28, 2025CULLEN/FROST BANKERS, INC.Restricted Stock UnitsStead Jimmy (GEVP Chief Consumer Banking)Stock award5,47700Not reported
Oct 30, 2025IMPINJ INCCommon StockDIORIO CHRIS PH.D. (CHIEF EXECUTIVE OFFICER · Director)Exercise / conversion23,50022.4526,400Not reported
Oct 30, 2025Cardlytics, Inc.Common StockGupta Srishti A. (Director)Exercise / conversion6,148Not reportedNot reportedNot reported
Oct 28, 2025CULLEN/FROST BANKERS, INC.Restricted Stock UnitsAlonzo Annette M (GEVP Chief HR Officer)Stock award4,26000Not reported
Oct 28, 2025ARTELO BIOSCIENCES, INC.Convertible Promissory NoteMATSUI CONNIE (Director)ConversionNot reported110,843Not reportedNot reported
Oct 28, 2025ARTELO BIOSCIENCES, INC.Warrant (right to buy)MATSUI CONNIE (Director)Conversion70,376Not reportedNot reportedNot reported
Oct 28, 2025ARTELO BIOSCIENCES, INC.Warrant (right to buy)MATSUI CONNIE (Director)Conversion38,346Not reportedNot reportedNot reported
Oct 28, 2025ARTELO BIOSCIENCES, INC.Convertible Promissory NoteFAVORITO TAMARA A (Director)ConversionNot reported19,793Not reportedNot reported
Oct 28, 2025ARTELO BIOSCIENCES, INC.Warrant (right to buy)FAVORITO TAMARA A (Director)Conversion12,566Not reportedNot reportedNot reported
Oct 28, 2025ARTELO BIOSCIENCES, INC.Warrant (right to buy)FAVORITO TAMARA A (Director)Conversion6,846Not reportedNot reportedNot reported
Oct 28, 2025ARTELO BIOSCIENCES, INC.Convertible Promissory NoteGorgas Gregory D. (President, CEO, Treasurer, Sec · Director)ConversionNot reported27,710Not reportedNot reported
Oct 28, 2025ARTELO BIOSCIENCES, INC.Warrant (right to buy)Gorgas Gregory D. (President, CEO, Treasurer, Sec · Director)Conversion17,952Not reportedNot reportedNot reported
Oct 28, 2025ARTELO BIOSCIENCES, INC.Warrant (right to buy)Gorgas Gregory D. (President, CEO, Treasurer, Sec · Director)Conversion9,586Not reportedNot reportedNot reported
Oct 28, 2025TaskUs, Inc.Class A Common StockWalsh Claudia F (General Counsel)Exercise / conversion16,847Not reportedNot reportedNot reported

Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transaction details

Reporting owners, quantities, prices, and source filings.

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Transacted: CULLEN/FROST BANKERS, INC.No current listing · company listings
Henson Matthew BradleyChief Accounting Officer
Stock awardRestricted Stock UnitsDerivative security · Code A7300Value: 0Not reportedView ↗
Transacted: CULLEN/FROST BANKERS, INC.No current listing · company listings
Geddes DanGEVP & Chief Financial Officer
Stock awardRestricted Stock UnitsDerivative security · Code A3,9560Value: 0Not reportedView ↗
Transacted: Primoris Services CorpPRIM · company listingsStock awardCommon StockNon-derivative security · Code A302Not reported *Value: Not reportedNot reportedView ↗
Transacted: CULLEN/FROST BANKERS, INC.No current listing · company listings
Wilson Kenneth L.GEVP Chief Wealth Officer
Stock awardRestricted Stock UnitsDerivative security · Code A3,3470Value: 0Not reportedView ↗
Transacted: CULLEN/FROST BANKERS, INC.No current listing · company listings
Kasanoff Howard L.GEVP Chief Credit Officer
Stock awardRestricted Stock UnitsDerivative security · Code A2,7390Value: 0Not reportedView ↗
Transacted: Primoris Services CorpPRIM · company listingsStock awardCommon StockNon-derivative security · Code A302Not reported *Value: Not reportedNot reportedView ↗
Transacted: NXP Semiconductors N.V.NXPI · company listings
Betz WilliamEVP & CFO
Stock awardRestricted Stock UnitDerivative security · Code A5,2130Value: 0Not reportedView ↗
Transacted: Catalyst Bancorp, Inc.CLST · company listingsPurchaseCommon StockNon-derivative security · Code P4,65013.4099Value: 62,356.035Not reportedView ↗
Transacted: Catalyst Bancorp, Inc.CLST · company listingsPurchaseCommon StockNon-derivative security · Code P10013.4Value: 1,340Not reportedView ↗
Transacted: CULLEN/FROST BANKERS, INC.No current listing · company listings
Rhodes Coolidge E JRGroup EVP General Counsel/Sec
Stock awardRestricted Stock UnitsDerivative security · Code A4,2600Value: 0Not reportedView ↗
Transacted: Janux Therapeutics, Inc.JANX · company listings
Meyer Andrew HollmanChief Business Officer
Exercise / conversionCommon StockNon-derivative security · Code M6,66610.59Value: 70,592.94Not reportedView ↗
Transacted: Janux Therapeutics, Inc.JANX · company listings
Meyer Andrew HollmanChief Business Officer
Exercise / conversionCommon StockNon-derivative security · Code M9,9994.21Value: 42,095.79Not reportedView ↗
Transacted: Primoris Services CorpPRIM · company listingsStock awardCommon StockNon-derivative security · Code A302Not reported *Value: Not reportedNot reportedView ↗
Transacted: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M10030.93Value: 3,093Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
van Houte HansChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,8580Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
van Houte HansChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,7500Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
van Houte HansChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,0000Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
van Houte HansChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,8860Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,8580Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,7500Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,0000Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
Ring ChristineChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,9240Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
Hansen GwennChief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,8580Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
Hansen GwennChief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,7500Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
Hansen GwennChief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,0000Value: 0Not reportedView ↗
Transacted: Nurix Therapeutics, Inc.NRIX · company listings
Hansen GwennChief Scientific Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,2070Value: 0Not reportedView ↗
Transacted: Bakkt, Inc.BKKT · company listingsStock awardClass A Common StockNon-derivative security · Code A1390Value: 0Not reportedView ↗
Transacted: NXP Semiconductors N.V.NXPI · company listings
Jensen Christopher LEVP, Chief People Officer
Stock awardRestricted Stock UnitDerivative security · Code A4,6490Value: 0Not reportedView ↗
Transacted: Sky Quarry Inc.SKYQ · company listings
Sealock DavidFormer CEO
Other acquisitionCommon SharesNon-derivative security · Code S100,0000.488Value: 48,800Not reportedView ↗
Transacted: CULLEN/FROST BANKERS, INC.No current listing · company listings
Severyn Carol JeanGEVP and Chief Risk Officer
Stock awardRestricted Stock UnitsDerivative security · Code A4,1380Value: 0Not reportedView ↗
Transacted: Travere Therapeutics, Inc.TVTX · company listings
Dube Eric MCHIEF EXECUTIVE OFFICER · Director
Exercise / conversionCommon StockNon-derivative security · Code M27,12815.46Value: 419,398.88Not reportedView ↗
Transacted: Travere Therapeutics, Inc.TVTX · company listings
Dube Eric MCHIEF EXECUTIVE OFFICER · Director
Exercise / conversionCommon StockNon-derivative security · Code M92,87215.46Value: 1,435,801.12Not reportedView ↗
Transacted: CHEMUNG FINANCIAL CORPCHMG · company listingsPurchaseCOMMON STOCKNon-derivative security · Code P2,18451.9231Value: 113,400.0504Not reportedView ↗
Transacted: Integer Holdings CorpITGR · company listings
Khales PaymanPresident & CEO · Director
PurchaseCommon StockNon-derivative security · Code P3,12764.94 *Value: 203,067.38Not reportedView ↗
Transacted: ROKU, INCROKU · company listings
Wood Anthony J.CEO and Chairman BOD · Director · 10% owner
ConversionClass A Common StockNon-derivative security · Code C18,700Not reported *Value: Not reportedNot reportedView ↗
Transacted: ROKU, INCROKU · company listings
Wood Anthony J.CEO and Chairman BOD · Director · 10% owner
ConversionClass A Common StockNon-derivative security · Code C2,900Not reported *Value: Not reportedNot reportedView ↗
Transacted: CULLEN/FROST BANKERS, INC.No current listing · company listings
Stead JimmyGEVP Chief Consumer Banking
Stock awardRestricted Stock UnitsDerivative security · Code A5,4770Value: 0Not reportedView ↗
Transacted: IMPINJ INCPI · company listings
DIORIO CHRIS PH.D.CHIEF EXECUTIVE OFFICER · Director
Exercise / conversionCommon StockNon-derivative security · Code M23,50022.4Value: 526,400Not reportedView ↗
Transacted: Cardlytics, Inc.CDLX · company listingsExercise / conversionCommon StockNon-derivative security · Code M6,148Not reported *Value: Not reportedNot reportedView ↗
Transacted: CULLEN/FROST BANKERS, INC.No current listing · company listings
Alonzo Annette MGEVP Chief HR Officer
Stock awardRestricted Stock UnitsDerivative security · Code A4,2600Value: 0Not reportedView ↗
Transacted: ARTELO BIOSCIENCES, INC.ARTL · company listingsConversionConvertible Promissory NoteDerivative security · Code CNot reported110,843Value: Not reportedNot reportedView ↗
Transacted: ARTELO BIOSCIENCES, INC.ARTL · company listingsConversionWarrant (right to buy)Derivative security · Code C70,376Not reported *Value: Not reportedNot reportedView ↗
Transacted: ARTELO BIOSCIENCES, INC.ARTL · company listingsConversionWarrant (right to buy)Derivative security · Code C38,346Not reported *Value: Not reportedNot reportedView ↗
Transacted: ARTELO BIOSCIENCES, INC.ARTL · company listingsConversionConvertible Promissory NoteDerivative security · Code CNot reported19,793Value: Not reportedNot reportedView ↗
Transacted: ARTELO BIOSCIENCES, INC.ARTL · company listingsConversionWarrant (right to buy)Derivative security · Code C12,566Not reported *Value: Not reportedNot reportedView ↗
Transacted: ARTELO BIOSCIENCES, INC.ARTL · company listingsConversionWarrant (right to buy)Derivative security · Code C6,846Not reported *Value: Not reportedNot reportedView ↗
Transacted: ARTELO BIOSCIENCES, INC.ARTL · company listings
Gorgas Gregory D.President, CEO, Treasurer, Sec · Director
ConversionConvertible Promissory NoteDerivative security · Code CNot reported27,710Value: Not reportedNot reportedView ↗
Transacted: ARTELO BIOSCIENCES, INC.ARTL · company listings
Gorgas Gregory D.President, CEO, Treasurer, Sec · Director
ConversionWarrant (right to buy)Derivative security · Code C17,952Not reported *Value: Not reportedNot reportedView ↗
Transacted: ARTELO BIOSCIENCES, INC.ARTL · company listings
Gorgas Gregory D.President, CEO, Treasurer, Sec · Director
ConversionWarrant (right to buy)Derivative security · Code C9,586Not reported *Value: Not reportedNot reportedView ↗
Transacted: TaskUs, Inc.TASK · company listings
Walsh Claudia FGeneral Counsel
Exercise / conversionClass A Common StockNon-derivative security · Code M16,847Not reported *Value: Not reportedNot reportedView ↗

Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →